The final results validate conclusions drawn by Bagli et al. [1], who done a analyze that integrated ten patients diagnosed with CRAO who been given HBOT. In combination with getting twenty classes of HBOT, oral acetazolamide and topical beta-blockers were administered towards the patients with the earliest achievable time.“Dr. Weber and his team